5 Keys to Marketing Pharmaceutical Products in a Post-COVID World

The pharmaceutical industry spends more money every year on marketing than it does on R&D. While NCBI (National Center for Biotechnology Information) studies show that for every new drug introduced to the market, nearly $2.6 Billion is invested prior to launch — as a general rule, most company’s overall expenses are more weighted toward marketing costs than R&D. In recent years Johnson & Johnson has spent more than $8 Billion on total marketing costs, more than double their R&D budget.